Metraipolis › archive › dc_b947d1908e67

The N6-methyladenosine-mediated cLMNB1 degrades FGFR4 to overcome osimertinib resistance in non-small cell lung cancer — Europe PMC PMID:41213916

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41213916
DOI
10.1038/s41419-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-08T16:54:07.699Z
SHA-256 of the archived text
ab5829b716d1f6c9c38b256e989cfb376d0c6da88ee992040744b234a0891359
Stable URL of this page
https://metraipolis.com/documento/dc_b947d1908e67

How to cite

The N6-methyladenosine-mediated cLMNB1 degrades FGFR4 to overcome osimertinib resistance in non-small cell lung cancer — Europe PMC PMID:41213916 — Europe PMC (en), https://europepmc.org/article/MED/41213916 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b947d1908e67 (Metraipolis archive dc_b947d1908e67, sha256 ab5829b716d1f6c9c38b256e989cfb376d0c6da88ee992040744b234a0891359)
BibTeX
@misc{dcb947d1908e67,
  title = {The N6-methyladenosine-mediated cLMNB1 degrades FGFR4 to overcome osimertinib resistance in non-small cell lung cancer — Europe PMC PMID:41213916},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41213916},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b947d1908e67; sha256 ab5829b716d1f6c9c38b256e989cfb376d0c6da88ee992040744b234a0891359},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41213916. Agents can read the archived copy with the MCP tool read_document.